Product
Cecolin®
1 clinical trial
1 indication
Indication
Cervical CancerClinical trial
Phase 3 Randomized, Active-Comparator Controlled, Open-Label Trial to Evaluate the Immunogenicity & Safety of Alternate 2-Dose Regimens of Cecolin® Compared to Gardasil® in 9-14 Year-Old Girls in Low and Low-Middle Income CountriesStatus: Completed, Estimated PCD: 2023-12-14